Skip to main content
SpringerLink
Log in

Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The inhibitory effect of omeprazole, a benzimidazole derivative, on gastric acid secretion was investigated in seven patients with Zollinger-Ellison syndrome resistant to treatment with large doses of histamine H2-receptor antagonists administered alone or in combination with pirenzepine. In two patients with an acute form of the syndrome, rapid control of acid overproduction was achieved with 180-mg intravenous and 120-mg oral daily doses, respectively. The other five patients, who were free of complication, initially received a standard regimen of omeprazole 60 mg orally once a day; dosage was subsequently adjusted until the basal acid output, measured 1 hr before the next dose of the drug, was less than 10 mmol/hr. The initial daily dose proved to be adequate in three patients and had to be increased to 80 mg and 60 mg bid, respectively in the remaining two patients. In all patients omeprazole therapy resulted in clinical recovery and rapid healing of mucosal lesions. The seven patients have now been followed up for 4–24 months (average 15 months). The adequacy of the daily dosage was periodically reassessed by measuring basal acid output in the hour preceding the morning dose. In one patient initially treated with 180 mg/day, dosage could be reduced to 60 mg/day. In three others, who were initially controlled with 60 mg/day, dosage had to be increased during follow-up. Despite adequate control of gastric acid secretion, one patient underwent total gastrectomy and tumor resection and another died of extensive liver metastases. The five patients still receiving omeprazole remain free of symptoms and mucosal lesions. No side effects or laboratory abnormalities ascribable to the drug were observed. It is concluded that omeprazole therapy is a good alternative in patients with Zollinger-Ellison resistant to currently available antisecretory drugs. Its safety and effectiveness in long-term therapy remain to be evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jensen RT, Gardner JD, Raufman J-P, Pandol SJ, Doppman JL, Collen MJ: Zollinger-Ellison syndrome: Current concepts and management. Ann Intern Med 98:59–75, 1983

    Google Scholar 

  2. Passaro E Jr, Stabile BE: Of gastrinomas and their management. Gastroenterology 84:1621–1623, 1983

    Google Scholar 

  3. Collen MJ, Howard JM, McArthur KE, Raufman J-P, Cornelius MJ, Ciarleglio CA, Gardner JD, Jensen RT: Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Intern Med 100:52–58, 1984

    Google Scholar 

  4. Jensen RT, Pandol SJ, Collen MJ, Raufman J-P, Gardner JD: Diagnosis and management of Zollinger-Ellison syndrome. J Clin Gastroenterol 5(Suppl 1):123–131, 1983

    Google Scholar 

  5. McCarthy DM: Report on the United States experience with cimetidine in Zollinger-Ellison syndrome and other hypersecretory states. Gastroenterology 74(2, pt 2):453–458, 1978

    Google Scholar 

  6. Mignon M, Vallot T, Hervoir P, Bendfredj JP, Bonfils S: Ranitidine versus cimetidine in the management of Zollinger-Ellison syndrome.In Ranitidine, Current Clinical Practice Series, Vol 1. AJ Riley, PR Salmon (eds). Amsterdam, Elsevier-Excerpta Medica, 1982, pp 169–177

    Google Scholar 

  7. Jensen RT, Collen MJ, Pandol SJ, Allende HD, Raufman JP, Bissonnette BM, Duncan WC, Durgin PL, Gillin JC and Gardner JD: Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. N Engl J Med 308:883–887, 1983

    Google Scholar 

  8. Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjöstrand SE, Wallmark B: Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+-K+)ATPase. Nature 290:159–161, 1981

    Google Scholar 

  9. Londong W, Londong V, Cederberg C, Steffen H: Doseresponse study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology 85:1373–1378, 1983

    Google Scholar 

  10. Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L: Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man. Gut 24:270–276, 1983

    Google Scholar 

  11. Konturek SJ, Cieszkowski M, Kwiecien N, Konturek J, Tasler J, Bilski J: Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs. Gastroenterology 86:71–77, 1984

    Google Scholar 

  12. Wilson JA, Boyd EJS, Wormsley KG: Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man. Dig Dis Sci 29:797–801, 1984

    Google Scholar 

  13. Prichard PJ, Yeomans ND, Mihaly GW, Jones DB, Buckle PJ, Smallwood RA, Louis WJ: Omeprazole: A study of its inhibition of gastric pH and oral pharmacokinetics after morning and evening dosage. Gastroenterology 88:64–69, 1985

    Google Scholar 

  14. Fellenius E, Elander B, Wallmark B, Helander HF, Berglindh T: Inhibition of acid secretion in isolated gastric glands by substituted benzimidazoles. Am J Physiol 243: G505-G510, 1982

    Google Scholar 

  15. Howden CW, Forrest JAH, Reid JL: Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut 25:707–710, 1984

    Google Scholar 

  16. Naesdal J, Bodemar G, Walan A: Effect of omeprazole, a substituted benzimidazole, on 24-hr intragastric acidity in patient with peptic ulcer disease. Scand J Gastroenterol 19:916–922, 1984

    Google Scholar 

  17. Walt RP, Gomes M de FA, Wood EC, Logan LH, Pounder RE: Effect of daily oral omeprazole on 24-hr intragastric acidity. Br Med J 287:12–14, 1983

    Google Scholar 

  18. Walt RP, Male P-J, Rawlings J, Hunt RH, Milton-Thompson GJ, Misiewicz JJ: Comparison of the effects of ranitidine, cimetidine and placebo on the 24-hr intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer. Gut 22:49–54, 1981

    Google Scholar 

  19. Lamers CBHW, Lind T, Moberg S, Jansen JBMJ, Olbe L: Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med 310:758–761, 1984

    Google Scholar 

  20. McArthur KE, Collen MJ, Maton PN, Cherner JA, Howard JM, Ciarleglio CA, Cornelius MJ, Jensen RT, Gardner JD: Omeprazole: Effective, convenient therapy for Zollinger-Ellison syndrome. Gastroenterology 88:939–944, 1985

    Google Scholar 

  21. McGuigan JE, Wolfe MM: Secretin injection test in the diagnosis of gastrinoma. Gastroenterology 79:1324–1331, 1980

    Google Scholar 

  22. Raufman J-P, Collins SM, Pandol SJ, Korman LY, Collen MJ, Cornelius MJ, Feld MK, McCarthy DM, Gardner JD, Jensen RT: Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome. Gastroenterology 84:108–113, 1983

    Google Scholar 

  23. Vallot T, Mignon M, Mazure R, Bonfils S: Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hr pH monitoring. Dig Dis Sci 28:577–584, 1983

    Google Scholar 

  24. Carney JA, Go VLW, Fairbanks VF, Moore SB, Alport EC, Nora FE: The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med 99:761–766, 1983

    Google Scholar 

  25. Wilander E: Achylia and the development of gastric carcinoids. Virchows Arch Pathol Anat 394:151–160, 1981

    Google Scholar 

  26. McCarthy DM: The place of surgery in the Zollinger-Ellison syndrome. N Engl J Med 302:1344–1347, 1980

    Google Scholar 

  27. Bonfils S, Mignon M, Landor JH: Management of Zollinger-Ellison syndrome. N Engl J Med 303:942, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité INSERUM 99, Hôpital Henri-Mondor, 94010, Créteil, France

    J. -C. Delchier, J. -C. Soule, M. Mignon, D. Goldfain, A. Cortot, B. Travers, J. -P. Isal & J. -P. Bader

  2. services d'hépato-gastroentérologie des hôpitaux, Henri-Mondor, Créteil, France

    J. -C. Delchier, J. -C. Soule, M. Mignon, D. Goldfain, A. Cortot, B. Travers, J. -P. Isal & J. -P. Bader

  3. Bichat, Paris, France

    J. -C. Delchier, J. -C. Soule, M. Mignon, D. Goldfain, A. Cortot, B. Travers, J. -P. Isal & J. -P. Bader

  4. de Dreux, Dreux, France

    J. -C. Delchier, J. -C. Soule, M. Mignon, D. Goldfain, A. Cortot, B. Travers, J. -P. Isal & J. -P. Bader

  5. de Lille, Lille, France

    J. -C. Delchier, J. -C. Soule, M. Mignon, D. Goldfain, A. Cortot, B. Travers, J. -P. Isal & J. -P. Bader

  6. Cochin, Paris, France

    J. -C. Delchier, J. -C. Soule, M. Mignon, D. Goldfain, A. Cortot, B. Travers, J. -P. Isal & J. -P. Bader

  7. Laboratoires ASTRA, France

    J. -C. Delchier, J. -C. Soule, M. Mignon, D. Goldfain, A. Cortot, B. Travers, J. -P. Isal & J. -P. Bader

Authors
  1. J. -C. Delchier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. -C. Soule
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Mignon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Goldfain
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Cortot
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Travers
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. -P. Isal
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. -P. Bader
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delchier, J.C., Soule, J.C., Mignon, M. et al. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists. Digest Dis Sci 31, 693–699 (1986). https://doi.org/10.1007/BF01296445

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01296445

Keywords

Search

Navigation